Breaking News Instant updates and real-time market news.

BCS

Barclays

$9.62

-0.005 (-0.05%)

, BNPQY

BNP Paribas

$0.00

(0.00%)

12:19
08/29/18
08/29
12:19
08/29/18
12:19

Judge dismisses bond rigging suit against large banks, Reuters reports

A U.S. judge has rejected an antitrust lawsuit by investors claiming that nine large banks rigged the roughly $9T government agency bond market from 2005 to 2015, Reuters reports. In a ruling made public on Wednesday, U.S. District Judge Edgardo Ramos in Manhattan determined that the investors failed to show they were harmed by conducting any specific transactions in U.S. dollar-denominated supranational, sub-sovereign, and agency bonds that were tainted by the alleged collusion, the report says. Investors led by the Iron Workers Pension Plan of Western Pennsylvania and the Sheet Metal Workers Pension Plan of Northern California claimed that the big banks used chatrooms and other means to share pricing information and coordinate trading to increase profit, infecting "each and every" transaction, the report says. Defendants in the case included Barclays (BCS), BNP Paribas (BNPQY), Citigroup (C), Credit Agricole (CRARY), Credit Suisse (CS), HSBC (HSBC), Nomura Holdings (NMR), Royal Bank of Canada (RY), and Toronto-Dominion Bank (TD), the report notes. Reference Link

BCS

Barclays

$9.62

-0.005 (-0.05%)

BNPQY

BNP Paribas

$0.00

(0.00%)

C

Citi

$72.70

0.31 (0.43%)

CRARY

Credit Agricole

$0.00

(0.00%)

CS

Credit Suisse

$15.26

0.095 (0.63%)

HSBC

HSBC

$45.09

0.18 (0.40%)

NMR

Nomura

$4.66

0.075 (1.64%)

RY

Royal Bank of Canada

$80.62

0.34 (0.42%)

TD

Toronto-Dominion

$61.25

0.185 (0.30%)

  • 30

    Aug

  • 20

    Sep

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

BCS Barclays
$9.62

-0.005 (-0.05%)

03/20/18
INVC
03/20/18
DOWNGRADE
INVC
Hold
Barclays downgraded to Hold from Buy at Investec
03/29/18
INVC
03/29/18
UPGRADE
INVC
Buy
Barclays upgraded to Buy from Hold at Investec
04/16/18
JEFF
04/16/18
UPGRADE
JEFF
Buy
Barclays upgraded to Buy from Hold at Jefferies
Jefferies analyst Joseph Dickerson upgraded Barclays to Buy and raised his price target for the shares to 265p from 205p. Activist Ed Bramson could help unlock significant value in the company's investment bank,Dickerson tells investors in a research note.
06/19/18
BOFA
06/19/18
DOWNGRADE
BOFA
Neutral
Barclays downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Andrew Stimpson downgraded Barclays to Neutral from Buy citing share outperformance and lack of significant revenue growth in 2018.
BNPQY BNP Paribas
$0.00

(0.00%)

11/20/17
KBWI
11/20/17
DOWNGRADE
KBWI
Market Perform
BNP Paribas downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Jean-Pierre Lambert downgraded earlier today BNP Paribas to Market Perform.
04/12/18
04/12/18
NO CHANGE

TSYS announces agreement with BNP Paribas subsidiary Bank of the West
TSYS (TSS) announced that it has signed a long-term agreement with Bank of the West, a subsidiary of BNP Paribas (BNPQY), where TSYS will provide support for the bank's commercial card program. Bank of the West will leverage TSYS' commercial card core processing platform, along with card and statement production, risk management tools and customer service support.
C Citi
$72.70

0.31 (0.43%)

08/28/18
WELS
08/28/18
NO CHANGE
Target $100
WELS
Outperform
Citi to benefit from potential U.S.-Mexico trade deal, says Wells Fargo
Wells Fargo analyst Mike Mayo believes Citi could gain more than other large U.S. banks from a U.S.-Mexico trade deal given its ownership of the second largest bank in Mexico, Citibanamex. In his view, Citi's stock had been hurt on perceptions of the U.S. relationship with Mexico. At a minimum, any new trade deal could reflect the absence of a negative and, on the upside, new potential growth opportunities, he contends. Mayo reiterates an Outperform rating and $100 price target on the shares.
07/27/18
RHCO
07/27/18
NO CHANGE
Target $240
RHCO
Buy
MasterCard price target raised to $240 from $215 at SunTrust
SunTrust analyst Andrew Jeffrey raised his price target on MasterCard to $240 and kept his Buy rating, saying the company is demonstrating expansion of global market share while posting a 14% Q2 volume growth. The analyst adds that while MasterCard has a higher valuation than PayPal (PYPL) and Visa (V) - a 10% relative EBITDA premium - it is justified and may even be too narrow given its superior growth sustainability and margin upside.
07/20/18
OPCO
07/20/18
NO CHANGE
OPCO
Perform
Wells Fargo's next few earnings reports likely to be 'choppy,' says Oppenheimer
Oppenheimer analyst Chris Kotowski maintained a Perform rating on Wells Fargo (WFC) after recent meetings with CFO John Shrewsberry. In a research note to investors, Kotowski says there was nothing that shakes his view that the next few quarterly earnings reports are likely to still be "choppy," and notes that Shewsberry "readily acknowledged" that there was much work to be done to get the consent order lifted. At the same time, the analyst contends that shares are not trading at much of a discount versus other high performing banks like JPMorgan (JPM) and PNC (PNC) and says he favors companies that have lower but rising ROTCEs that are trading near TBV, especially Citi (C), CIT (CIT) and Goldman (GS).
07/16/18
BMOC
07/16/18
NO CHANGE
Target $85
BMOC
Market Perform
Citi price target raised to $85 from $76 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Citi to $85 after its Q2 earnings beat that was driven by better than expected investment banking and credit growth. The analyst also states that Citi's Q2 capital markets-related revenues were higher than expected, while the provisions for loan losses were lower than previously modeled. Fotheringham notes that Citi stock is "cheap again" following a 10% year-to-date decline, trading at only a 6.8-times two-year forward core earnings relative to its 9.5-times historical multiple.
CRARY Credit Agricole
$0.00

(0.00%)

CS Credit Suisse
$15.26

0.095 (0.63%)

01/16/18
LEHM
01/16/18
INITIATION
LEHM
Underweight
Credit Suisse initiated with an Underweight at Barclays
Barclays analyst Amit Goel started Credit Suisse with an Underweight rating and CHF 15.4 price target. The analyst thinks the company's new targets for 2019 and 2020 will not be achieved, along with some of the targets for 2018. He sees 16% downside potential from current share levels.
01/16/18
01/16/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Axalta Coating (AXTA) resumed with an Underperform at BofA/Merrill. 2. UBS (UBS) and Credit Suisse (CS) were initiated with an Underweight at Barclays. 3. Nutrien (NTR) initiated with a Neutral at Goldman Sachs. 4. Cambrex (CBM) initiated with an Outperform at William Blair. 5. Dicerna (DRNA) initiated with an Outperform at Evercore ISI. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/15/18
SOCG
02/15/18
UPGRADE
SOCG
Buy
Credit Suisse upgraded to Buy from Hold at Societe Generale
02/15/18
02/15/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Bristol-Myers (BMY) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Risinger saying he has become more optimistic on the immuno-oncology Opdivo + Yervoy combo in first-line lung cancer, which he notes is the largest cancer market. 2. Salesforce (CRM) upgraded to Buy from Hold at Jefferies with analyst John DiFucci saying recent field checks indicate continued strong enterprise traction as well improved commercial segment momentum, likely due to moderating Microsoft (MSFT) competition. 3. Credit Suisse (CS) upgraded to Buy from Hold at Societe Generale. 4. FMC Corporation (FMC) upgraded to Buy from Neutral at Seaport Global with analyst Michael Harrison saying he sees near-term catalysts from the Ag market recovery and secular growth in lithium, which the company plans to spinoff. 5. Baidu (BIDU) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Grace Chen citing expectations for search sales reacceleration in 2018, the potential catalyst of the iQiyi IPO and the long-term potential contributions from AI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
HSBC HSBC
$45.09

0.18 (0.40%)

05/07/18
LYON
05/07/18
UPGRADE
LYON
Buy
HSBC upgraded to Buy from Outperform at CLSA
07/10/18
JPMS
07/10/18
UPGRADE
JPMS
Overweight
HSBC upgraded to Overweight from Neutral at JPMorgan
07/11/18
JPMS
07/11/18
UPGRADE
JPMS
Overweight
JPMorgan sees value in HSBC after pullback, upgrades to Overweight
JPMorgan analyst Katherine Lei last night upgraded HSBC to Overweight from Neutral and raised her price target for the shares to HKD 92 from HKD 88. Despite stable asset quality and an improving net interest margin outlook, HSBC's share price corrected 14% from the peak in January, Lei tells investors in a research note. The analyst sees value in the shares at current levels.
07/11/18
07/11/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Myriad Genetics (MYGN) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Steve Beuchaw saying the core HCT business is showing more durability, with volumes returning to growth and price declines slowing, while the acquisitions of Assurex and Counsyl are diversifying the company into higher growth and improving average selling price testing markets. 2. HSBC (HSBC) upgraded to Overweight from Neutral at JPMorgan with analyst Katherine Lei saying despite stable asset quality and an improving net interest margin outlook, HSBC's share price corrected 14% from the peak in January. 3. Conn's (CONN) upgraded to Buy from Hold at Stifel with analyst John Baugh saying he left a recent meeting with management feeling confident that the recent indications of improvement in the credit segment should continue. 4. TripAdvisor (TRIP) upgraded to Overweight from Equal Weight at Barclays with analyst Deepak Mathivanan saying the company's fundamentals "are starting to turn around." 5. Imperial Oil (IMO) upgraded to Equal Weight from Underweight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
NMR Nomura
$4.66

0.075 (1.64%)

01/05/18
JPMS
01/05/18
UPGRADE
JPMS
Overweight
Nomura upgraded to Overweight from Neutral at JPMorgan (pre-open)
01/19/18
GSCO
01/19/18
UPGRADE
GSCO
Buy
Nomura upgraded to Buy from Neutral at Goldman Sachs
05/02/18
DAIW
05/02/18
DOWNGRADE
DAIW
Outperform
Nomura downgraded to Outperform from Buy at Daiwa
08/01/18
DAIW
08/01/18
DOWNGRADE
DAIW
Neutral
Nomura downgraded to Neutral from Outperform at Daiwa
RY Royal Bank of Canada
$80.62

0.34 (0.42%)

08/23/18
BMOC
08/23/18
NO CHANGE
Target $110
BMOC
Market Perform
Royal Bank of Canada price target raised to $110 from $106 at BMO Capital
BMO Capital analyst Sohrab Mohavedi raised his price target on Royal Bank of Canada to $110 after its Q2 earnings beat that was driven by higher-multiple Wealth operations. The analyst adds that the 500bps boost to operating leverage in the Canadian Banking segment contributed to 150bps increase in the overall leverage. Mohavedi also cites RBC's "good" credit conditions, improved Common Equity Tier 1 ratio, and raised dividend payout, but keeps his Market Perform rating, noting that its return to U.S. retail banking will "likely" dilute the overall ROE.
06/08/18
MACQ
06/08/18
UPGRADE
MACQ
Neutral
Royal Bank of Canada upgraded to Neutral from Underperform at Macquarie
06/04/18
NATB
06/04/18
UPGRADE
NATB
Outperform
Royal Bank of Canada upgraded to Outperform from Sector Perform at National Bank
02/01/18
CIBC
02/01/18
DOWNGRADE
CIBC
Neutral
Royal Bank of Canada downgraded to Neutral from Outperformer at CIBC
TD Toronto-Dominion
$61.25

0.185 (0.30%)

10/24/17
MACQ
10/24/17
INITIATION
Target $61
MACQ
Outperform
Toronto-Dominion initiated with an Outperform at Macquarie
Macquarie analyst Mike Rizvanovic initiated Toronto-Dominion with an Outperform and $61 price target.
02/01/18
CIBC
02/01/18
UPGRADE
CIBC
Outperformer
Toronto-Dominion upgraded to Outperformer from Neutral at CIBC
03/02/18
DESJ
03/02/18
UPGRADE
DESJ
Buy
Toronto-Dominion upgraded to Buy from Hold at Desjardins
Desjardins analyst Doug Young upgraded Toronto-Dominion to Buy with a C$84 price target.
05/25/18
BMOC
05/25/18
NO CHANGE
Target $82
BMOC
Outperform
Toronto-Dominion price target raised to $82 from $79 at BMO Capital
BMO Capital analyst Sohrab Movahedi raised his price target on TD Bank to $82 after its Q2 earnings beat, citing strength in the Canadian retail. The analyst notes 17% growth in the segment's P&C banking as well as the 16% rise in Wealth & Insurance. Movahedi adds that TD's core equity tier 1 ratio was a "solid" 11.8%, giving the bank "excess" capital position. The analyst keeps his Outperform rating on TD Bank.

TODAY'S FREE FLY STORIES

02:40
12/13/18
12/13
02:40
12/13/18
02:40
General news
FX Update: A risk-on theme has been coursing through forex markets »

FX Update: A risk-on…

01:45
12/13/18
12/13
01:45
12/13/18
01:45
General news
Asian Market Wrap: »

Asian Market Wrap:…

BHVN

Biohaven Pharmaceutical

$37.72

1.02 (2.78%)

20:51
12/12/18
12/12
20:51
12/12/18
20:51
Syndicate
Biohaven Pharmaceutical 3.3M share Secondary priced at $37.25 per share »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

FIVE

Five Below

$101.38

1.86 (1.87%)

20:48
12/12/18
12/12
20:48
12/12/18
20:48
Upgrade
Five Below rating change at Goldman Sachs »

Five Below upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRNS

Marinus Pharmaceuticals

$4.21

-0.89 (-17.45%)

20:28
12/12/18
12/12
20:28
12/12/18
20:28
Syndicate
Marinus Pharmaceuticals 12M share Secondary priced at $3.75 per share »

Jefferies and Leerink are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

UNM

Unum Group

$30.27

-0.04 (-0.13%)

20:25
12/12/18
12/12
20:25
12/12/18
20:25
Hot Stocks
Unum Group sees FY19 adjusted EPS growth of 4%-7% »

Sees FY19 tax rate of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

CIEN

Ciena

$32.14

0.535 (1.69%)

20:25
12/12/18
12/12
20:25
12/12/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

TDC

Teradata

$38.02

0.65 (1.74%)

20:18
12/12/18
12/12
20:18
12/12/18
20:18
Hot Stocks
Teradata targets 2021 recurring revenue growth of 14% »

Also sees 2021 gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 19

    Dec

  • 20

    Dec

HESM

Hess Midstream Partners

$19.43

0.38 (1.99%)

19:09
12/12/18
12/12
19:09
12/12/18
19:09
Hot Stocks
Hess Midstream Partners sees FY19 adjusted EBITDA $550M-$575M »

Sees FY19: net income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOCA

Tocagen

$11.22

-1.63 (-12.68%)

19:05
12/12/18
12/12
19:05
12/12/18
19:05
Syndicate
Tocagen 3M share Secondary priced at $10.00 per share »

Citi and Leerink are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

ALL

Allstate

$82.37

-0.12 (-0.15%)

19:03
12/12/18
12/12
19:03
12/12/18
19:03
Hot Stocks
Allstate announces estimated November catastrophe losses of $685M »

Allstate announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$76.04

-0.64 (-0.83%)

19:01
12/12/18
12/12
19:01
12/12/18
19:01
Hot Stocks
Exxon makes final investment decision to develop West Barracouta gas project »

ExxonMobil said that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$111.83

1.09 (0.98%)

, JCS

Communications Systems

$2.42

0.2 (9.01%)

19:00
12/12/18
12/12
19:00
12/12/18
19:00
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

NDSN

Nordson

$111.83

1.09 (0.98%)

JCS

Communications Systems

$2.42

0.2 (9.01%)

BW

Babcock & Wilcox

$0.77

0.0569 (7.94%)

FIVE

Five Below

$101.38

1.86 (1.87%)

BABA

Alibaba

$151.49

-0.34 (-0.22%)

TLRD

Tailored Brands

$20.16

0.32 (1.61%)

LLNW

Limelight Networks

$3.20

0.025 (0.79%)

OXM

Oxford Industries

$74.88

0.895 (1.21%)

AGTC

Applied Genetic

$6.61

0.54 (8.90%)

VBIV

VBI Vaccines

$1.66

0.08 (5.06%)

HASI

Hannon Armstrong

$23.10

-0.16 (-0.69%)

BVN

Buenaventura

$15.25

0.22 (1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 04

    Mar

  • 12

    Mar

  • 13

    Dec

  • 13

    Dec

OXM

Oxford Industries

$74.88

0.895 (1.21%)

18:58
12/12/18
12/12
18:58
12/12/18
18:58
Earnings
Oxford Industries cuts FY18 EPS view to $4.20-$4.35 from $4.45-$4.65 »

Cuts FY18 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

OXM

Oxford Industries

$74.88

0.895 (1.21%)

18:56
12/12/18
12/12
18:56
12/12/18
18:56
Earnings
Oxford Industries sees Q4 EPS 96c-$1.11 vs. 93c last year »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

OXM

Oxford Industries

$74.88

0.895 (1.21%)

18:55
12/12/18
12/12
18:55
12/12/18
18:55
Earnings
Oxford Industries reports Q3 adjusted EPS 14c vs. 17c last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

NEXT

NextDecade

$4.74

0.04 (0.85%)

18:30
12/12/18
12/12
18:30
12/12/18
18:30
Hot Stocks
NextDecade's Rio Grande LNG project approved by TCEQ »

NextDecade Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$89.63

1.49 (1.69%)

18:15
12/12/18
12/12
18:15
12/12/18
18:15
Periodicals
United CEO seeks to boost flight network by 4%-6% next year, Reuters says »

United Airlines CEO Oscar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

AKAO

Achaogen

$1.80

0.06 (3.45%)

17:58
12/12/18
12/12
17:58
12/12/18
17:58
Hot Stocks
Breaking Hot Stocks news story on Achaogen »

Robert Duggan raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLR

Fluor

$34.11

0.29 (0.86%)

17:56
12/12/18
12/12
17:56
12/12/18
17:56
Hot Stocks
Fluor announces participation in $2.1B rail project in Chicago »

Fluor announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIVE

Five Below

$101.38

1.86 (1.87%)

17:55
12/12/18
12/12
17:55
12/12/18
17:55
Upgrade
Five Below rating change at Goldman Sachs »

Five Below upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

17:49
12/12/18
12/12
17:49
12/12/18
17:49
Hot Stocks
SEC says former execs behind allegedly fraudulent ICO settle scam charges »

Two former executives…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PK

Park Hotels & Resorts

$29.28

0.08 (0.27%)

17:44
12/12/18
12/12
17:44
12/12/18
17:44
Hot Stocks
Park Hotels & Resorts announces Q4 dividend of $1.00 per share »

Park Hotels & Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PK

Park Hotels & Resorts

$29.28

0.08 (0.27%)

17:44
12/12/18
12/12
17:44
12/12/18
17:44
Hot Stocks
Park Hotels & Resorts announces Q4 dividend of $1.00 per share »

Park Hotels & Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNP

CenterPoint Energy

$28.90

0.12 (0.42%)

17:37
12/12/18
12/12
17:37
12/12/18
17:37
Hot Stocks
CenterPoint Energy raises dividend 4% to 28.75c per share »

The company's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.